Artificial Intelligence Law And Digitalisation In Law

Healthcare Under The EU AI Act: Risks, Rights, And Responsibility In European Framework

Artificial intelligence (AI) is transforming healthcare in Europe, offering unprecedented opportunities for diagnosis, treatment, and patient monitoring while raising profound legal and ethical challenges. The European Union (EU)’s Artificial Intelligence Act (AI Act), enacted in 2024, represents the world’s first comprehensive regulatory framework for AI and establishes a risk-based approach that automatically classifies all healthcare applications of AI as “high-risk.” This article provides an in-depth analysis of the AI Act’s implications for the healthcare sector, situating it within the EU’s broader tradition of rights-based digital governance and examining its interaction with existing regimes such as the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR). The discussion explores how the AI Act redefines the responsibilities of developers, providers, healthcare institutions, and professionals through obligations of transparency, data governance, documentation, and human oversight. It also evaluates the ethical and human rights dimensions of the Act, linking provisions on bias, opacity, and accountability to the Charter of Fundamental Rights of the European Union (CFEU). Special attention is paid to the compliance burdens facing small and medium-sized enterprises (SMEs), which often drive innovation in health technology but face disproportionate challenges under the current regulatory model.

Samet Tatar
DOI: 10.53478/TUBA.978-625-6110-66-3.ch10